+622.4%
CVNA vs EMR
+60.1%
+562.3%
-53.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.8% | -1.2% | -0.6% | -0.7% |
| 7D | -1.0% | +0.9% | -1.9% | -1.8% |
| 30D | -1.0% | -5.0% | +3.9% | +3.2% |
| 3M | +5.5% | +5.9% | -0.5% | -1.1% |
| 6M | +11.8% | +7.3% | +4.5% | +2.8% |
| YTD | -13.0% | +14.6% | -27.6% | -25.9% |
| 1Y | -2.1% | +15.6% | -17.8% | -18.2% |
| All | +622.4% | +60.1% | +562.3% | +372.8% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling